You might also like
Weave Communications, Inc. is a company that provides a comprehensive, all-in-one customer experience and payments software platform specifically designed for small- and medium-sized healthcare businesses (SMBs). The platform unifies, modernizes, and personalizes interactions between healthcare practitioners and their patients or clients by integrating various functionalities into a single solution. Weave sells software and phone services, payment processing services, and hardware to enhance the efficiency of healthcare practices.
- Subscription and Payment Processing - Offers recurring subscription fees for software and phone services, along with payment processing services, serving as the primary revenue driver.
- Hardware - Provides phone hardware, with revenue recognized over the subscription period.
- Onboarding - Includes non-recurring revenue from installation fees for onboarding new customers.
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
Alan Taylor Executive | Chief Financial Officer (CFO) | None | Alan Taylor has been CFO since June 2016. He is retiring at the end of Q1 2025, with Jason Christiansen set to succeed him. | |
Branden Neish Executive | Chief Product and Technology Officer | None | Branden Neish joined Weave in April 2022 as Chief Product Officer and was promoted to Chief Product and Technology Officer in January 2023. He leads product and technology strategy. | |
Brett White Executive | Chief Executive Officer (CEO) | None | Brett White has been CEO since at least March 2023. He oversees Weave's strategic direction and operations. No prior roles at Weave are mentioned. | View Report → |
David McNeil Executive | Chief Revenue Officer (CRO) | None | David McNeil joined Weave in February 2024. He has over 25 years of experience in scaling SaaS businesses and previously held leadership roles at HubSpot and Salesforce. | |
Erin Goodsell Executive | Chief Legal Officer | None | Erin Goodsell joined Weave in July 2022 as Chief Legal Officer and Corporate Secretary. She oversees legal and corporate governance matters. | |
Jason Christiansen Executive | Vice President of Finance (Incoming CFO) | None | Jason Christiansen joined Weave in 2021 and is currently VP of Finance. He will transition to CFO at the end of Q1 2025. He played a key role in Weave's IPO and business transformation. | |
Marcus Bertilson Executive | Chief Operating Officer (COO) | None | Marcus Bertilson joined Weave in May 2023 as Chief Strategy and Services Officer and was promoted to COO in March 2024. He leads operations and partnerships. | |
Blake G. Modersitzki Board | Director | Managing Partner at Pelion Venture Partners; Board Member at Deserve, Inc. and BusBot, Inc. | Blake G. Modersitzki has been a director since October 2015. He has extensive experience in venture capital and technology investments. | |
David Silverman Board | Director | Managing Partner at Crosslink Capital | David Silverman has been a director since October 2015. He is a venture capital investor with expertise in financial technologies. | |
Debora Tomlin Board | Director | Board Member at LiveRamp Holdings, Inc. and Nexla, Inc.; Advisor to Blumberg Capital | Debora Tomlin has been a director since December 2020. She has expertise in technology marketing and public company leadership. | |
George P. Scanlon Board | Director | Board Member at Landstar System, Inc. | George P. Scanlon has been a director since May 2022. He is an audit committee chairperson and financial expert with extensive CFO experience. | |
Stuart C. Harvey Jr. Board | Chairperson of the Board | Senior Advisor to Blackstone; Board Member at Engage2Excel, Inc. and Affinipay | Stuart C. Harvey Jr. has been Chairperson since September 2021. He brings extensive leadership and financial expertise. | |
Tyler Newton Board | Director | Partner at Catalyst Investors | Tyler Newton has been a director since August 2017. He has extensive experience in growth equity investing and technology company leadership. |
-
Your revenue growth guidance for 2025 implies a deceleration compared to 2024, despite strong momentum in specialty medical verticals, partnerships, payments, and AI initiatives. Can you clarify what specific headwinds are causing this conservative outlook, and when do you expect these growth vectors to materially impact your top-line growth?
-
Given that you're not planning to implement the same level of price increases in 2025 as you did in 2024, how confident are you in achieving the same or higher revenue growth without these pricing tailwinds, especially as you lap the significant price adjustments in Q2?
-
With the recent investments in payments and AI, including embedding payments into initial sales and changing the sales compensation model, why aren't you projecting a more significant contribution from these initiatives in your 2025 guidance, and what challenges are you encountering in scaling these offerings?
-
Your Gross Revenue Retention (GRR) slightly decreased to 91% in Q4, at the lower end of your historical range. What factors contributed to this decline, and what steps are you taking to improve customer retention and prevent further erosion in GRR?
-
Considering that your operating expenses are expected to increase due to compliance with Section 404(b) of Sarbanes-Oxley and other investments, how do you plan to balance these increased costs with profitability goals, and what measures are in place to ensure continued operating margin improvement?
No recent press releases or 8-K filings found for WEAV.